Ekso Bionics (NASDAQ:EKSO) Price Target Raised to $10.00 at HC Wainwright

Ekso Bionics (NASDAQ:EKSO) had its target price increased by analysts at HC Wainwright from $9.25 to $10.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock.

Separately, StockNews.com upgraded shares of Ekso Bionics from a “sell” rating to a “hold” rating in a report on Thursday, April 4th.

Ekso Bionics Stock Performance

Shares of EKSO stock opened at $1.28 on Tuesday. The firm has a 50-day moving average of $1.47 and a 200-day moving average of $1.63. The company has a market cap of $23.08 million, a P/E ratio of -1.31 and a beta of 1.61. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.49 and a quick ratio of 1.87. Ekso Bionics has a one year low of $0.62 and a one year high of $3.13.

Ekso Bionics (NASDAQ:EKSO) last announced its earnings results on Monday, April 29th. The company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.04). The firm had revenue of $3.76 million during the quarter, compared to analysts’ expectations of $4.99 million. Ekso Bionics had a negative net margin of 79.48% and a negative return on equity of 93.53%. During the same quarter in the prior year, the company earned ($0.33) EPS. Equities research analysts forecast that Ekso Bionics will post -0.49 EPS for the current fiscal year.

Institutional Trading of Ekso Bionics

An institutional investor recently raised its position in Ekso Bionics stock. Strategic Wealth Investment Group LLC increased its stake in shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) by 25.8% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 42,665 shares of the company’s stock after buying an additional 8,752 shares during the period. Strategic Wealth Investment Group LLC owned about 0.30% of Ekso Bionics worth $31,000 as of its most recent SEC filing. 6.42% of the stock is owned by institutional investors and hedge funds.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.